Korean name: CLA FFA. This page reports what South Korea's
Ministry of Food and Drug Safety has approved for this ingredient.
MFDS recognition no.
2006-28
Approval route
Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)
9.0–11.0
Approval holder
동부한농화학(주)
Approved functional claim (Korean original)
The text below is the approved wording as published by MFDS. It is reproduced without
modification. Any translation is provided for comprehension only and carries no regulatory
standing.
“공액리놀레산(Conjugated Linoleic Acid)는 과체중인 성인의 체지방 감소에 도움을 줄 수 있습니다.”
(과체중인 성인을 대상으로 한 인체시험에서 CLA를 섭취한 경우 체지방(fat mass)감소에 도움을 줄 수 있음이 많은 자료에서 확인되었으나 한국인을 대상으로 한 자료가 없었음. 따라서 반드시 ‘---에 도움을 줄 수 있습니다’의 형식으로 표시하여야 함.)
Precautions (Korean original)
1. 위장장애가 발생할 수 있습니다.
2. 영유아, 임산부는 섭취를 삼가야 합니다.
3. 식사조절, 운동을 병행하는 것이 바람직합니다.
What this means for sourcing
An ingredient approved in Korea is not automatically permitted elsewhere. Importers should
verify status with their own authority. Conversely, Korean approval demonstrates that a dossier
on safety and function was reviewed under a national regulatory system, which many buyers treat
as a meaningful signal.
Regulatory approvals described on this page were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts; it does not recommend or endorse any product.